Publications by authors named "Rudolf Benz"

Claim this Profile
I
Ibrutinib lead-in followed by venetoclax plus ibrutinib for relapsed/refractory chronic lymphocytic leukemia: the SAKK 34/17 trial.
Adalgisa Condoluci, Ilaria Romano, Daniel Dietrich, Katia Pini, Georg Stüssi, Rudolf Benz

Blood· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line venetoclax combinations versus chemoimmunotherapy in fit patients with chronic lymphocytic leukaemia (GAIA/CLL13): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial.
Moritz Fürstenau, Arnon P Kater, Sandra Robrecht, Julia von Tresckow, Can Zhang, Rudolf Benz

Lancet Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Significance of the Myelodysplastic Syndrome-Specific Comorbidity Index (MDS-CI) in Patients with Myelofibrosis: A Retrospective Study.
Kira-Lee Koster, Nora-Medea Messerich, Thomas Volken, Sergio Cogliatti, Thomas Lehmann, Rudolf Benz

Cancers (Basel)· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CRP/Albumin Ratio and Glasgow Prognostic Score Provide Prognostic Information in Myelofibrosis Independently of MIPSS70-A Retrospective Study.
Nora-Medea Messerich, Narasimha Rao Uda, Thomas Volken, Sergio Cogliatti, Thomas Lehmann, Rudolf Benz

Cancers (Basel)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CALR loss-of-heterozygosity as a potential driver for extramedullary AML.
Marie-Christine Weller, Eugenia Haralambieva, Marco Matteo Bühler, Rudolf Benz, Alexandre Pierre André Theocharides

Ann Hematol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Data From the Swiss Lenalidomide in MDS del(5q) (SLIM)-Registry Identify New Chances and Challenges in Lenalidomide Treatment of Patients With MDS del(5q).
Axel Rüfer, Hubert Angermann, Rudolf Benz, Nicolas Bonadies, Antonello Calderoni

Hemasphere· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Rudolf Benz

Ther Umsch· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world impact of primary immune thrombocytopenia and treatment with thrombopoietin receptor agonists on quality of life based on patient-reported experience: Results from a questionnaire conducted in Switzerland, Austria, and Belgium.
Alicia Rovó, Nathan Cantoni, Kaveh Samii, Axel Rüfer, Giedre Koenen, Rudolf Benz

PLoS One· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Myelodysplastic/myeloproliferative neoplasia: a diagnostic and therapeutic challenge].
Rudolf Benz

Ther Umsch· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoimmune Hematologic Disorders in Two Patients After mRNA COVID-19 Vaccine.
Marie-Estelle Gaignard, Sven Lieberherr, Andreas Schoenenberger, Rudolf Benz

Hemasphere· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision Medicine.
Ioannis Chanias, Kristina Stojkov, Gregor Th Stehle, Michael Daskalakis, Helena Simeunovic, Rudolf Benz

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survey on Recommended Health Care for Adult Patients with Myelodysplastic Syndromes Identifies Areas for Improvement.
Ioannis Chanias, C Matthias Wilk, Rudolf Benz, Michael Daskalakis, Georg Stüssi

Int J Environ Res Public Health· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pegylated interferon can control myelodysplastic/myeloproliferative syndrome with ring sideroblasts and thrombocytosis.
Rudolf Benz, Kathrin Zimmermann, Markus Rechsteiner, Stefan Balabanov, Markus G Manz

Leuk Lymphoma· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial.
Rudolf Benz, Kornelius Arn, Martin Andres, Thomas Pabst, Michael Baumann

Blood Adv· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The sympathomimetic agonist mirabegron did not lower -V617F allele burden, but restored nestin-positive cells and reduced reticulin fibrosis in patients with myeloproliferative neoplasms: results of phase II study SAKK 33/14.
Beatrice Drexler, Jakob R Passweg, Alexandar Tzankov, Martin Bigler, Alexandre Pa Theocharides, Rudolf Benz

Haematologica· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends of incidence and survival of patients with chronic myelomonocytic leukemia between 1999 and 2014: A comparison between Swiss and American population-based cancer registries.
Sonia Benzarti, Michael Daskalakis, Anita Feller, Vera Ulrike Bacher, Annatina Schnegg-Kaufmann, Rudolf Benz

Cancer Epidemiol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microarray-based comparative genomic hybridisation reveals additional recurrent aberrations in adult patients evaluated for myelodysplastic syndrome with normal karyotype.
Ines Ouahchi, Luduo Zhang, Ramon Benitez Brito, Rudolf Benz, Rouven Müller

Br J Haematol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neisseria elongata infection associated with complement inhibition during treatment of paroxysmal nocturnal haemoglobinuria.
Rudolf Benz, Martin Krause, Sabine Majer, Christian Taverna, Kathrin Herzog

Br J Haematol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of liver magnetic resonance imaging in hyperferritinaemia and the diagnosis of iron overload.
Axel Ruefer, Christine Bapst, Rudolf Benz, Jens Bremerich, Nathan Cantoni

Swiss Med Wkly· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
sIL2R ratio as early marker for response in hairy cell leukemia and the prognostic relevance of IL28B genotype to interferon-α therapy.
Stéphanie Jud, Jeroen S Goede, Oliver Senn, Katharina Spanaus, Markus G Manz, Rudolf Benz

Ann Hematol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends of classification, incidence, mortality, and survival of MDS patients in Switzerland between 2001 and 2012.
Nicolas Bonadies, Anita Feller, Alicia Rovo, Axel Ruefer, Sabine Blum, Rudolf Benz

Cancer Epidemiol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexpected cause of high fever in the blood film.
Rudolf Benz, Sabine Majer

Blood· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Azacitidine in De Novo and Relapsed Acute Myeloid Leukemia: A Retrospective Comparative Study.
Cornelia Gemuenden, Rudolf Benz, Oliver Senn, Jeroen S Goede, Markus G Manz

Clin Lymphoma Myeloma Leuk· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brentuximab as a treatment for CD30+ mycosis fungoides and Sézary syndrome.
Tarun Mehra, Kristian Ikenberg, Rudolf Maria Moos, Rudolf Benz, Gayathri Nair

JAMA Dermatol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disseminated ulcerating lupus panniculitis emerging under interferon therapy of hairy cell leukemia: treatment- or disease-related?
Mirjana Urosevic-Maiwald, Stephan Nobbe, Katrin Kerl, Rudolf Benz

J Dermatol· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis